M.F. is supported by a Cancer Research UK Senior Fellowship (C10701/A15181), the European Research Council (ERC; 310360), and the Medical Research Council UK (MR/M01939X/1). S.D. is funded by an EMBO Long-Term Fellowship. Part of this work was carried out in the framework of the European COST action EPITRAN 16120
Centre for Trophoblast Reearch Royal Society Dorothy Hodgkin Fellowship Marie Curie Intra-European Fellowship
Centre for Trophoblast Reearch Royal Society Dorothy Hodgkin Fellowship Marie Curie Intra-European Fellowship
This entry reviews the structure, function and clinical significance of YEATS4, a gene originally identified from an amplicon on 12p15 found in a glioblastoma cell line and originally named glioma-amplified sequence (GAS41). The gene is amplified in several other cancers and translocations or rearrangements of chromosome 12 with breakpoints in YEAT...
ALCAM (Activated Leukocyte Cell Adhesion Molecule), also known as CD166 (cluster of differentiation 166), is a member of a subfamily of immunoglobulin receptors with five immunoglobulin-like domains (VVC2C2C2) in the extracellular domain.
Engineering and Physical Sciences Research Council (EPSRC) grants EP/P505445/1, EP/J500380/1 and EP/N019938/1, Geistlich Pharma AG (of which PG Buxton and M Mehr are employees) and European Research Council (ERC) Advanced Grant 320598-3D-E
Engineering and Physical Sciences Research Council (EPSRC) grants EP/P505445/1, EP/J500380/1 and EP/N019938/1, Geistlich Pharma AG (of which PG Buxton and M Mehr are employees) and European Research Council (ERC) Advanced Grant 320598-3D-E
Engineering and Physical Sciences Research Council (EPSRC) grants EP/P505445/1, EP/J500380/1 and EP/N019938/1, Geistlich Pharma AG (of which PG Buxton and M Mehr are employees) and European Research Council (ERC) Advanced Grant 320598-3D-E
Engineering and Physical Sciences Research Council (EPSRC) grants EP/P505445/1, EP/J500380/1 and EP/N019938/1, Geistlich Pharma AG (of which PG Buxton and M Mehr are employees) and European Research Council (ERC) Advanced Grant 320598-3D-E
Engineering and Physical Sciences Research Council (EPSRC) grants EP/P505445/1, EP/J500380/1 and EP/N019938/1, Geistlich Pharma AG (of which PG Buxton and M Mehr are employees) and European Research Council (ERC) Advanced Grant 320598-3D-E
